Tandem Diabetes Care (TNDM) Other Non-Current Assets (2013 - 2026)

Tandem Diabetes Care has reported Other Non-Current Assets for 14 years, with the latest figure at $30.8 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 312.89% year-over-year to $30.8 million; the trailing twelve-month figure through Mar 2026 stood at $30.8 million (up 312.89% YoY), and the FY2025 full-year result was $22.9 million, up 342.62% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $30.8 million, up from $22.9 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $40.3 million in Q4 2023, with the low at $5.2 million in Q4 2024.
• Historically, Other Non-Current Assets has averaged $22.6 million across 5 years, with a median of $17.6 million in 2023.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 87.19% — and 2025, when it soared 342.62%.
• Tandem Diabetes Care's Other Non-Current Assets stood at $23.6 million in 2022, then jumped by 70.69% to $40.3 million in 2023, then sank by 87.19% to $5.2 million in 2024, then soared by 342.62% to $22.9 million in 2025, then surged by 34.78% to $30.8 million in 2026.
• The last three Other Non-Current Assets figures came in at $30.8 million (Q1 2026), $22.9 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.